These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 3198197
1. Haemoglobin adducts of aromatic amines in people exposed to cigarette smoke. Bryant MS, Vineis P, Skipper PL, Tannenbaum SR. IARC Sci Publ; 1988; (89):133-6. PubMed ID: 3198197 [Abstract] [Full Text] [Related]
2. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels. Landi MT, Zocchetti C, Bernucci I, Kadlubar FF, Tannenbaum S, Skipper P, Bartsch H, Malaveille C, Shields P, Caporaso NE, Vineis P. Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060 [Abstract] [Full Text] [Related]
3. CYP1A2 and NAT2 phenotyping and 3-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in smokers and non-smokers. Sarkar M, Stabbert R, Kinser RD, Oey J, Rustemeier K, von Holt K, Schepers G, Walk RA, Roethig HJ. Toxicol Appl Pharmacol; 2006 Jun 15; 213(3):198-206. PubMed ID: 16405939 [Abstract] [Full Text] [Related]
4. Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County. Jiang X, Yuan JM, Skipper PL, Tannenbaum SR, Yu MC. Cancer Res; 2007 Aug 01; 67(15):7540-5. PubMed ID: 17671226 [Abstract] [Full Text] [Related]
5. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels. Probst-Hensch NM, Bell DA, Watson MA, Skipper PL, Tannenbaum SR, Chan KK, Ross RK, Yu MC. Cancer Epidemiol Biomarkers Prev; 2000 Jun 01; 9(6):619-23. PubMed ID: 10868698 [Abstract] [Full Text] [Related]
6. Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco. Bryant MS, Vineis P, Skipper PL, Tannenbaum SR. Proc Natl Acad Sci U S A; 1988 Dec 01; 85(24):9788-91. PubMed ID: 3200858 [Abstract] [Full Text] [Related]
7. Nonsmoking-related arylamine exposure and bladder cancer risk. Skipper PL, Tannenbaum SR, Ross RK, Yu MC. Cancer Epidemiol Biomarkers Prev; 2003 Jun 01; 12(6):503-7. PubMed ID: 12814994 [Abstract] [Full Text] [Related]
8. Black (air-cured) and blond (flue-cured) tobacco cancer risk. IV: Molecular dosimetry studies implicate aromatic amines as bladder carcinogens. Bartsch H, Malaveille C, Friesen M, Kadlubar FF, Vineis P. Eur J Cancer; 1993 Jun 01; 29A(8):1199-207. PubMed ID: 8518034 [Abstract] [Full Text] [Related]
9. Biomonitoring of smoke constituents: exposure to 4-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in nonsmokers and smokers. Schorp MK, Leyden DE. Inhal Toxicol; 2010 Aug 01; 22(9):725-37. PubMed ID: 20433335 [Abstract] [Full Text] [Related]
10. Effects of timing and type of tobacco in cigarette-induced bladder cancer. Vineis P, Esteve J, Hartge P, Hoover R, Silverman DT, Terracini B. Cancer Res; 1988 Jul 01; 48(13):3849-52. PubMed ID: 3378220 [Abstract] [Full Text] [Related]
11. The use of 4-aminobiphenyl hemoglobin adducts and aromatic DNA adducts in lymphocytes of smokers as biomarkers of exposure. Dallinga JW, Pachen DM, Wijnhoven SW, Breedijk A, van 't Veer L, Wigbout G, van Zandwijk N, Maas LM, van Agen E, Kleinjans JC, van Schooten FJ. Cancer Epidemiol Biomarkers Prev; 1998 Jul 01; 7(7):571-7. PubMed ID: 9681524 [Abstract] [Full Text] [Related]
12. DNA adducts, protein adducts, and sister chromatid exchange in cigarette smokers and nonsmokers. Perera FP, Santella RM, Brenner D, Poirier MC, Munshi AA, Fischman HK, Van Ryzin J. J Natl Cancer Inst; 1987 Sep 01; 79(3):449-56. PubMed ID: 3114532 [Abstract] [Full Text] [Related]
13. Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers. Bryant MS, Skipper PL, Tannenbaum SR, Maclure M. Cancer Res; 1987 Jan 15; 47(2):602-8. PubMed ID: 3791245 [Abstract] [Full Text] [Related]
14. 4-Aminobiphenyl hemoglobin adducts in fetuses exposed to the tobacco smoke carcinogen in utero. Coghlin J, Gann PH, Hammond SK, Skipper PL, Taghizadeh K, Paul M, Tannenbaum SR. J Natl Cancer Inst; 1991 Feb 20; 83(4):274-80. PubMed ID: 1994056 [Abstract] [Full Text] [Related]
15. Relationship between environmental tobacco smoke exposure and carcinogen-hemoglobin adduct levels in nonsmokers. Hammond SK, Coghlin J, Gann PH, Paul M, Taghizadeh K, Skipper PL, Tannenbaum SR. J Natl Cancer Inst; 1993 Mar 17; 85(6):474-8. PubMed ID: 8445675 [Abstract] [Full Text] [Related]
16. Hemoglobin adducts of the human bladder carcinogen o-toluidine after treatment with the local anesthetic prilocaine. Gaber K, Harréus UA, Matthias C, Kleinsasser NH, Richter E. Toxicology; 2007 Jan 05; 229(1-2):157-64. PubMed ID: 17129655 [Abstract] [Full Text] [Related]
17. Analysis of DNA adducts in smokers' lung and urothelium by 32P-postlabelling: metabolic phenotype dependence and comparisons with other exposure markers. Bartsch H, Castegnaro M, Camus AM, Schouft A, Geneste O, Rojas M, Alexandrov K. IARC Sci Publ; 1993 Jan 05; (124):331-40. PubMed ID: 8225503 [Abstract] [Full Text] [Related]
18. Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity. Talaska G, Schamer M, Skipper P, Tannenbaum S, Caporaso N, Unruh L, Kadlubar FF, Bartsch H, Malaveille C, Vineis P. Cancer Epidemiol Biomarkers Prev; 1991 Jan 05; 1(1):61-6. PubMed ID: 1845172 [Abstract] [Full Text] [Related]
19. Haemoglobin adducts from aromatic amines and tobacco specific nitrosamines in pregnant smoking and non smoking women. Birgit Branner Cornelia Kutzer Wolfgang Wickenpflug Gerhard Scherer Wolf-Dieter Heller Elmar Richter. Biomarkers; 1998 Jan 05; 3(1):35-47. PubMed ID: 23899255 [Abstract] [Full Text] [Related]
20. 4-Aminobiphenyl-hemoglobin adducts and risk of smoking-related disease in never smokers and former smokers in the European Prospective Investigation into Cancer and Nutrition prospective study. Airoldi L, Vineis P, Colombi A, Olgiati L, Dell'Osta C, Fanelli R, Manzi L, Veglia F, Autrup H, Dunning A, Garte S, Hainaut P, Hoek G, Krzyzanowski M, Malaveille C, Matullo G, Overvad K, Tjonneland A, Clavel-Chapelon F, Linseisen J, Boeing H, Trichopoulou A, Palli D, Peluso M, Krogh V, Tumino R, Panico S, Bueno-De-Mesquita HB, Peeters PH, Lund E, Agudo A, Martinez C, Dorronsoro M, Barricarte A, Chirlaque MD, Quiros JR, Berglund G, Järvholm B, Hallmans G, Day NE, Allen N, Saracci R, Kaaks R, Riboli E. Cancer Epidemiol Biomarkers Prev; 2005 Sep 05; 14(9):2118-24. PubMed ID: 16172219 [Abstract] [Full Text] [Related] Page: [Next] [New Search]